Breadcrumb

[A08-01] Rapid-acting insulin analogues in children and adolescents with diabetes mellitus type 1 - follow-up commission

Overview

Overview

Commission: Commission awarded on 2008-07-17 by the Federal Joint Committee (G-BA)
Status:Commission completed
Department/Division:Drug Assessment
Current document:PDF Executive summary of the final report  [PDF, 57 kB]Further documents
Contact address:to the contact form
Linked projects: [A05-02] Rapid-acting insulin analogues in the treatment of diabetes mellitus type 1
Status: Commission completed


Report documents

Report documents

PublishedDocumentSizeType 
2009-11-16 Executive summary of the final report 57 kBPDFdownload file
2009-11-16 Final report (German version) 2 MBPDFdownload file
2009-11-16 Documentation and appraisal of comments on the preliminary report (German version) 3 MBPDFdownload file
2009-07-02 Executive summary of the preliminary report (German version) 158 kBPDFdownload file
2009-07-02 Preliminary report (German version) 786 kBPDFdownload file
2009-03-09 Report plan version 1.0 (German version) 203 kBPDFdownload file
2009-03-09 Documentation and appraisal of comments on the report plan (preliminary version) (German version) 2 MBPDFdownload file
2008-09-23 Report plan - preliminary version (German version) 125 kBPDFdownload file


At a glance

Accompanying information

Executive summary to the final report

  File-Icon  Rapid-acting insulin analogues in children and adolescents with diabetes mellitus type 1 [PDF, 57 kB]

Health information

Further information for consumers and patients is provided on IQWiG's health information website www.informedhealthonline.org.

Type 1 diabetes: Are short-acting insulin analogues better than human insulin?

Press releases

2009-11-16 Rapid-acting insulin analogues: Trials provide no proof of additional benefit for children and adolescents with type 1 diabetes



Save result list

To save your search result, please copy the link below and paste it into a new tab/window.

close